Primary Cutaneous Non-Hodgkin Lymphoma

Observed

→ investigated in trials for

Cyclophosphamidesmall molecule

20 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Rituximabmonoclonal antibody

17 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Romidepsinother

16 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mogamulizumabmonoclonal antibody

15 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Brentuximab Vedotinadc

14 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Etoposidesmall molecule

14 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lenalidomidesmall molecule

12 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pembrolizumabmonoclonal antibody

11 trials (8 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vorinostatsmall molecule

10 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Busulfansmall molecule

8 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Methotrexatesmall molecule

7 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Belinostatsmall molecule

6 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mechlorethaminesmall molecule

6 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alemtuzumabmonoclonal antibody

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Primary Cutaneous Non-Hodgkin Lymphoma studied in …STUDIED_INderived10 of 352show all (up to 200)
→ studied in	NCT01087333recruiting Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment · condition mapped ALIAS · 352 trials mapped (87 active)	—	—	Primary Cutaneous T-Cell Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05627245Phase 1 · active not recruiting Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment · condition mapped CURATED_BROADER · 352 trials mapped (87 active)	—	—	Primary Cutaneous T-Cell Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05944562Phase 1 · active not recruiting Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome · condition mapped ONTOLOGY_EXACT · 352 trials mapped (87 active)	—	—	Mycosis Fungoides	1	Observed	clinicaltrials	graph →
→ studied in	NCT07003100recruiting A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab · condition mapped CURATED_BROADER · 352 trials mapped (87 active)	—	—	Mycosis Fungoides	1	Observed	clinicaltrials	graph →
→ studied in	NCT05589896Phase 1/Phase 2 · active not recruiting A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies · condition mapped ALIAS · 352 trials mapped (87 active)	—	—	Primary Cutaneous T-Cell Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07710781NA · not yet recruiting Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies · condition mapped ALIAS · 352 trials mapped (87 active)	—	—	Primary Cutaneous T-Cell Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06285370Phase 4 · completed A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy · condition mapped ALIAS · 352 trials mapped (87 active)	—	—	Primary Cutaneous T-Cell Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06854653Phase 2 · recruiting A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL · condition mapped ALIAS · 352 trials mapped (87 active)	—	—	Primary Cutaneous T-Cell Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03380026Phase 2 · completed Mechlorethamine Induced Contact Dermatitis Avoidance Study · condition mapped ALIAS · 352 trials mapped (87 active)	—	—	Primary Cutaneous T-Cell Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04930653Phase 2 · recruiting Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 352 trials mapped (87 active)	—	—	Folliculotropic Mycosis Fungoides	1	Observed	clinicaltrials	graph →

Primary Cutaneous Non-Hodgkin Lymphoma studied in …STUDIED_INderived10 of 352show all (up to 200)

→ studied in

NCT01087333recruiting

Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment · condition mapped ALIAS · 352 trials mapped (87 active)

—

Observed

→ studied in

NCT05627245Phase 1 · active not recruiting

Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment · condition mapped CURATED_BROADER · 352 trials mapped (87 active)

—

Observed

→ studied in

NCT05944562Phase 1 · active not recruiting

Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome · condition mapped ONTOLOGY_EXACT · 352 trials mapped (87 active)

—

Mycosis Fungoides

Observed

→ studied in

NCT07003100recruiting

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab · condition mapped CURATED_BROADER · 352 trials mapped (87 active)

—

Mycosis Fungoides

Observed

→ studied in

NCT05589896Phase 1/Phase 2 · active not recruiting

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies · condition mapped ALIAS · 352 trials mapped (87 active)

—

Observed

→ studied in

NCT07710781NA · not yet recruiting

Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies · condition mapped ALIAS · 352 trials mapped (87 active)

—

Observed

→ studied in

NCT06285370Phase 4 · completed

A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy · condition mapped ALIAS · 352 trials mapped (87 active)

—

Observed

→ studied in

NCT06854653Phase 2 · recruiting

A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL · condition mapped ALIAS · 352 trials mapped (87 active)

—

Observed

→ studied in

NCT03380026Phase 2 · completed

Mechlorethamine Induced Contact Dermatitis Avoidance Study · condition mapped ALIAS · 352 trials mapped (87 active)

—

Observed

Folliculotropic Mycosis Fungoides

→ studied in

NCT04930653Phase 2 · recruiting

Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 352 trials mapped (87 active)

—

Observed